# Risk Assessment of Febrile Neutropenia and Grade 3-4 Neutropenia in Patients With Non-hematological Cancer Treated With Conventional Chemotherapy

> **NCT01799421** · — · COMPLETED · sponsor: **Asociación para el Fomento de la Investigación y el Desarrollo Integral de la Oncología** · enrollment: 420 (actual)

## Conditions studied

- Non-hematologic Cancer

## Interventions

_None listed._

## Key facts

- **NCT ID:** NCT01799421
- **Lead sponsor:** Asociación para el Fomento de la Investigación y el Desarrollo Integral de la Oncología
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** COMPLETED
- **Start date:** 2011-10
- **Primary completion:** 2014-12
- **Final completion:** 2015-12
- **Target enrollment:** 420 (ACTUAL)
- **Last updated:** 2016-11-21


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01799421

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01799421, "Risk Assessment of Febrile Neutropenia and Grade 3-4 Neutropenia in Patients With Non-hematological Cancer Treated With Conventional Chemotherapy". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT01799421. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*